Opaleye Management Inc. Cytokinetics Inc Transaction History

Opaleye Management Inc.

$390 Million
Q2 2024

A detailed history of Opaleye Management Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Opaleye Management Inc. holds 198,500 shares of CYTK stock, worth $11.1 Million. This represents 2.75% of its overall portfolio holdings.

Number of Shares

198,500

Holding current value

$11.1 Million

% of portfolio

2.75%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $9.5 Million - $14.9 Million	198,500 New	198,500 $10.8 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $2.53 Million - $3.16 Million	-77,500 Reduced 37.35%	130,000 $4.24 Million
Q1 2023 May 12, 2023	SELL	$33.36 - $45.71 $1.42 Million - $1.94 Million	-42,500 Reduced 17.0%	207,500 $7.3 Million
Q4 2022 Feb 10, 2023	SELL	$35.77 - $51.11 $465,010 - $664,430	-13,000 Reduced 4.94%	250,000 $11.5 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $1.52 Million - $2.15 Million	-39,500 Reduced 13.06%	263,000 $12.7 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $3.53 Million - $5.09 Million	-104,000 Reduced 25.58%	302,500 $11.9 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $5.16 Million - $7.98 Million	-173,500 Reduced 29.91%	406,500 $15 Million
Q1 2021 May 18, 2021	SELL	$18.57 - $25.68 $51,996 - $71,904	-2,800 Reduced 0.48%	580,000 $13.5 Million
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $5.71 Million - $10.7 Million	374,000 Added 179.12%	582,800 $12.1 Million
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $1.94 Million - $2.73 Million	-94,250 Reduced 31.1%	208,800 $4.52 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $3.38 Million - $7.47 Million	303,050 New	303,050 $7.14 Million

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

126M

Call Options Held

3.29M

Put Options Held

2.01M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.26B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Account

Opaleye Management Inc. Cytokinetics Inc Transaction History